Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2007

View Archived Issues

AS-605858: A selective PI3K gamma inhibitor for the treatment of inflammatory conditions

Health Canada approves Astellas' antifungal treatment Mycamine

Injection of the GAD gene into the brain is safe in Parkinson's disease patients

New approaches in the management of bipolar disorder

ICAgen and McNeil terminate senicapoc collaboration

Metabasis Therapeutics initiates phase Ib trial of MB-07811 for hyperlipidemia

Ceregene and Genzyme establish CERE-120 partnership

GPC Biotech licenses satraplatin to Yakult for Japan

Rotigotine beneficial in restless legs syndrome, Parkinson's disease studies

Levetiracetam evaluated in children with ADHD and restless legs syndrome

Pregabalin improves sleep in fibromyalgia patients

Interferon beta-1a reduces fatigue in multiple sclerosis patients

Roche's emerging franchise in RA now includes Toyama Chemical's T-5224

TransOral changes name to Transcept

SkyePharma Inc. changes name to Pacira

Cytokinetics and GSK extend research term under collaboration

New phase II trial studies Cotara in glioblastoma multiforme

Corlux mitigates weight gain associated with olanzapine

Encouraging data for NG2-73 in chronic insomnia

Modigene develops long-acting, proprietary versions of approved therapeutic proteins

Revlimid receives full E.U. approval for multiple myeloma

Four-type human papillomavirus vaccine Gardasil recommended worldwide

Recent GSK patent discloses novel therapeutic agents for gastrointestinal disorders

Recent Cytopia patent divulges new immunosuppressant agents

Recent patents disclose novel agents for obesity and lipoprotein metabolism disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026